WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 6'5801 Infant (under 12 months) mortality rate: 212
GDP / capita (US$): 10'6631 Child (under 5 years) mortality rate: 232

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 109  109  109  109  109  108  108  101 
Births
Surviving infants
Pop. less than 5 years 11  13  15 
Pop. less than 15 years 28  28  29  29  29  34  41  44 
Female 15-49 years 29  29  29  29  29  28  25  23 

Number of reported case

(Click for retrospective incidence data for Saint Vincent and the Grenadines)
Diphtheria
Japanese encephalitis
Measles 257 
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Saint Vincent and the Grenadines)
Vaccine year result method % card seen                                                
BCG          96  97  100  91  80  100  100 
DTP1          96  94  94  94  99*  91 
DTP3          99*  96  96  100  99*  100  98  26 
HepB_BD          20  60  70 
HepB3          99*  96  96  100  99* 
Hib3          99*  97  96  99*  99* 
JapEnc         
MCV          100  94  99*  100  99*  96  96 
MCV2          96  92  99*  89  94 
PCV1         
PCV3         
Pol3          99*  96  96  100  99*  100  92  26 
Rota1         
Rota_last         
Rubella1          100  94  99*  100  99* 
TT2plus          10  11 
PAB         
VAD1         
YFV          10  30 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Saint Vincent and the Grenadines)
BCG 96  97  99  90  80  99  99 
DTP1 96  98  98  99  99  99  98  51 
DTP3 96  96  96  99  99  98  98  26 
HepB3 96  96  96  99  99 
HepB_BD
Hib3 97  97  96  99  99 
MCV 99  94  97  99  99  96  96 
MCV2 96  92  91  89  94 
PCV3
Pol3 96  96  96  99  99  99  92  26 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth-12 months; Yes
DT 4-5 years; Yes
DTwP 18 months; Yes
DTwPHibHep 2, 4, 6 months; Yes
HepB 1st contact; +1, +4-6 months; Yes at birth for hepatitis b exposed babies and adult at risk
HIB 2, 4, 6 months; children who started vaccination overseas
IPV 2, 4, 6, 18 months; 4-5 years; Yes HIV+
MMR 1, 4-5 years; Yes
OPV 2, 4, 6, 18 months; 4-5 years; Yes
Td >10 years; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  Yes  Yes  Yes 
What years does the MYP cover? number         2009-2011  2009-2011  2'007 
Nº of districts with microplans that include activities to raise immunization coverage number

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  89  100  100  100  89 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 56  56  78  56  89  89   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.